CME in Minutes: Education in Ophthalmology - Adam S. Wenick, MD, PhD - Keeping Sight of Adherence with VEGF-Targeted Therapy: Individualized Dosing Strategies to Improve Care for nAMD

Adam S. Wenick, MD, PhD - Keeping Sight of Adherence with VEGF-Targeted Therapy: Individualized Dosing Strategies to Improve Care for nAMD

01/04/23 • 13 min

CME in Minutes: Education in Ophthalmology

Please visit answersincme.com/AXS860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, Dr. Adam S. Wenick, an expert in ophthalmology, discusses treatment adherence in neovascular age-related macular degeneration (nAMD). Upon completion of this activity, participants should be better able to: Recognize the clinical impact of available intravitreal vascular endothelial growth factor– (VEGF-) targeted therapies for neovascular age-related macular degeneration (nAMD); Outline practical strategies to individualize intravitreal VEGF-targeted treatment selection and dosing for patients with nAMD; and Review patient counseling approaches to improve treatment adherence to intravitreal VEGF-targeted therapies for nAMD.

Next Episode

George Oral Waring IV, MD, FACS - Up Close With Presbyopia: Novel Emerging Miotic Agents for Aging Eyes

Please visit answersincme.com/EUA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses new treatments for patients with presbyopia. Upon completion of this activity, participants should be better able to:Recognize the unmet therapeutic needs with available presbyopia treatments; Describe the evidence for late-stage emerging miotic agents being developed to treat presbyopia; and Outline strategies to individualize treatment selection for patients with presbyopia.